1Department of Pathology, Yale University School of Medicine, New Haven, Connecticut. 2Department of Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, Sotiria ...

If both genetic parents are Rh-negative, their children will be, too. The pregnant parent should have their blood type, including Rh factor, tested and antibody screening done if indicated as part of ...

Of the candidates that the San Diego-based company is now prioritizing for internal development, the most advanced is an anti-AXL antibody-drug conjugate called mecbotamab vedotin. BioAtla said ...

But promising results from a recent clinical trial suggest that broadly neutralizing antibody therapy (bNAbs) may be able to accomplish the next best thing. Data from the trial—a collaboration ...

Dr. James Hansen, a Yale Cancer Center researcher, and his team discovered that using an antibody related to lupus they can breach the tumor and trigger an immune response to fight it. He says ...

New antibody-drug conjugate (ADC) candidate, ZW327, exhibits anti-tumor activity and a favorable pharmacokinetics profile in Ly6E-bearing cancers VANCOUVER, British Columbia, March 25, 2025 (GLOBE ...

The scores also enable researchers to assess the spatial relationships critical to the mechanisms of antibody–drug conjugates (ADCs), such as the bystander effect, where a drug impacts not only the ...

24 ug sheared chromatin sample collected from each time point (ZT3, ZT15) was incubated with 12ul of rabbit polyclonal antibody against ZFHX3 (Parsons et al., 2015), together with magnetic beads, on a ...

为探究影响口腔鳞状细胞癌（OSCC）对免疫检查点抑制剂（ICIs）反应的因素，研究人员通过单细胞测序分析新辅助化疗免疫治疗（NACI）对 OSCC 肿瘤微环境的影响，发现相关细胞亚群和作用机制，为治疗提供新靶点。 # 口腔鳞状细胞癌新辅助免疫化疗的深度探索 ...

The Dren Bio therapy is part of a growing trend of research into autoimmune disease medicines that can reset the immune system instead of suppressing it. The work is built on promising results in ...

In the latest investment in the immunology space, Sanofi has agreed to a $600 million upfront payment to buy Dren Bio’s investigational bispecific antibody DR-0201 in a deal announced Thursday. The ...